Pernod Ricard (RI) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
15 Jan, 2026Opening remarks and agenda
The meeting was convened in compliance with legal and regulatory requirements, with a provisional quorum of 80.88% established, and legal documents were made available to shareholders.
Financial performance review
Organic revenue was stable at -1% to +1% (excluding Russia), with recurring operating income up 1.5% and margin up 80 basis points, despite challenging conditions in key markets.
Free cash flow was €963m, down 13% to 33%, and net debt/EBITDA rose to 3.1x, mainly due to strategic CapEx and lower free cash flow.
Net profit declined by 35% to €1,476m, impacted by non-recurring expenses, higher financial costs, and wine sector disposal.
U.S. organic revenue fell 9% due to retailer destocking and inflation, China saw a >10% decline, while India became the second-largest market with strong growth.
Over five years, average annual growth was 5%, within the medium-term target range of 3–7%.
Board and executive committee updates
The board comprised a majority of independent directors, with strong diversity in gender and nationality, and will have 14 members post-meeting.
Board skills cover management, finance, audit, CSR, innovation, and digital, with a 97.95% attendance rate over 10 meetings.
Five dedicated committees (Audit, Nominations & Governance, Compensation, Strategic, CSR) supported the Board's responsibilities.
Wolfgang Colberg retired from the board; committee work included audit, governance, compensation, strategy, and CSR.
Lead Independent Director engaged with main investors and ensured conflict of interest prevention.
Latest events from Pernod Ricard
- Sales and profit fell, but free cash flow improved and medium-term growth targets reaffirmed.RI
H1 202619 Feb 2026 - Q1 organic sales fell 7.6%, but H2 is expected to improve as key markets recover.RI
Q1 20263 Feb 2026 - Organic sales down 1%, margins up, net profit down 35%, FY25 growth expected.RI
H2 202423 Jan 2026 - Q1 sales declined 5.9% organically, with China and US driving the downturn; guidance unchanged.RI
Q1 202519 Jan 2026 - Margin and cash flow improved despite sales and profit declines amid FX and China headwinds.RI
H1 20259 Jan 2026 - Resilient results, stable dividends, and all resolutions approved amid global challenges.RI
AGM 202527 Dec 2025 - Q3 FY25 organic net sales fell 3%, but FY25 outlook and €2.35 dividend were confirmed.RI
Q3 202521 Dec 2025 - Organic sales fell 3% but margin and cash flow improved; FY26 to be a transition year.RI
H2 202523 Nov 2025 - Sharpened pricing, focused portfolio, and stronger wholesaler ties drive renewed brand momentum.RI
Investor Update18 Nov 2025